Thitima Pewklang Selected Research

Neoplasms (Cancer)

12/2023	Revolutionary Pyrazole-based Aza-BODIPY: Harnessing Photothermal Power Against Cancer Cells and Bacteria.
1/2023	Quercetin Nanoparticle-Based Hypoxia-Responsive Probe for Cancer Detection.
1/2022	Aza-BODIPY based carbonic anhydrase IX: Strategy to overcome hypoxia limitation in photodynamic therapy.
8/2021	Flavylium-Based Hypoxia-Responsive Probe for Cancer Cell Imaging.
1/2021	One-Pot Synthesis of Coumarin-Indomethacin Hybrids as COX-2 Targeting Probes for Cancer Imaging.
1/2021	Glucose conjugated aza-BODIPY for enhanced photodynamic cancer therapy.
4/2019	Aza-BODIPY probe for selective visualization of cyclooxygenase-2 in cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thitima Pewklang Research Topics

Disease

7	Neoplasms (Cancer) 12/2023 - 04/2019
3	Hypoxia (Hypoxemia) 01/2023 - 08/2021
1	Bacterial Infections (Bacterial Infection) 12/2023
1	Triple Negative Breast Neoplasms 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Adenocarcinoma 01/2021

Drug/Important Bio-Agent (IBA)

4	azaBDPBA compoundIBA 12/2023 - 04/2019
1	pyrazoleIBA 12/2023
1	QuercetinIBA 01/2023
1	FlavonoidsIBA 01/2023
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2022
1	Carbonic Anhydrase IXIBA 01/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022
1	Coloring Agents (Dyes)IBA 08/2021
1	diphenyliodoniumIBA 08/2021
1	Oxidoreductases (Dehydrogenase)IBA 08/2021
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2021
1	coumarinIBA 01/2021
1	Singlet OxygenIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2019

Therapy/Procedure

2	Therapeutics 12/2023 - 01/2021
1	Photothermal Therapy 12/2023
1	Photochemotherapy (Photodynamic Therapy) 01/2022